Cannara Biotech
A disclosed public position — held with the same temperament we apply to private holdings.
Cannara Biotech is listed on the Toronto Stock Exchange under the ticker LOVE. The family disclosed a position of approximately 4% in 2024, taken with no intention of trading around quarterly noise.
Specific transaction history, average cost basis and any subsequent block movements are held in the family's internal records and are not published.[1]
Why we own it.
We took the Cannara position because we wanted a disclosed public position we could hold the same way we hold a private one: undisturbed by the daily quote, and sized so a drawdown does not change our behaviour.
How we treat the position.
We do not trade around earnings, we do not lend the stock, and we do not comment on management's quarterly performance. The same operating temperament we apply to wholly-owned platforms is applied here.
Selected public sources cited in this page. Internal operating figures are not linked.
- 01Cons Family Holdings — internal position recordINTERNALCons Family Holdings, internal archivePosition size, cost basis and disclosure timing. Internal — no link.